Biochemical and functional characterization of Epstein-Barr virus-encoded BARF1 protein: Interaction with human hTid1 protein facilitates its maturation and secretion

Oncogene

Volumn 25, Issue 31, 2006, Pages 4320-4331

  Wang, L ^a   Tam, J P ^a   Liu, D X ^a,b  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

Author keywords

BARF1; Epstein Barr virus; Human hTid1; Interaction; Maturation and secretion

Indexed keywords

AMINO ACID; ASPARAGINE; CYSTEINE; HYBRID PROTEIN; PROTEIN BARF1; PROTEIN HTID1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CELL LABELING; CELL MATURATION; CHEMICAL ANALYSIS; GLYCOSYLATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN INTERACTION; PROTEIN PROCESSING; PROTEIN SECRETION; SCREENING; SITE DIRECTED MUTAGENESIS; YEAST;

HELA CELLS; HERPESVIRUS 4, HUMAN; HSP40 HEAT-SHOCK PROTEINS; HUMANS; PROTEIN FOLDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; VIRAL PROTEINS;

HUMAN HERPESVIRUS 4; MAMMALIA;

EID: 33746266752     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209458     Document Type: Article

References (28)

1. Bork P, Sander C, Valencia A. (1992). Proc Natl Acad Sci 89: 7290-7294.
2. Cheetham ME, Caplan AJ. (1998). Cell Stress Chaperones 3: 28-36.
3. Cheng H, Cenciarelli C, Shao Z, Vidal M, Parks WP, Pagano M et al. (2001). Curr Biol 11: 1771-1775.
4. Cheng H, Cenciarelli C, Tao M, Parks WP, Cheng-Mayer C. (2002). J Biol Chem 277: 20605-20610.
5. Cohen JI, Lekstrom K. (1999). J Virol 73: 7627-7632.
6. Danve C, Decaussin G, Busson P, Ooka T. (2001). Virology 288: 223-235.
7. Decaussin G, Sbih-Lammali F, De Turenne-Tessier M, Bouguermouh A, Ooka T. (2000). Cancer Res 60: 5584-5588.
8. De Turenne-Tessier M, Jolicoeur P, Middeldorp JM, Ooka T. (2005). Virus Research 109: 9-18.
9. Eom CY, Lehman IR. (2002). Proc Natl Acad Sci 99: 1894-1898.
10. Kieff E. (1996) In: BN Fields, Knipe DM and Howley PM (eds). Fields Virology, 3rd edn. Lippincott-Raven Publishers: Philadelphia, PA, p 2343-2396.
11. Kim SW, Chao TH, Xiang R, Lo JF, Campbell MJ, Fearns C et al. (2004). Cancer Res 64: 7732-7739.
12. Liu DX, Xu HY, Brown TDK. (1997). J Virol 71: 1814-1820.
13. Mayer MP. (2005). Rev Physiol Biochem Pharmacol 153: 1-46.
14. Nishikawa J, Imai S, Oda T, Kojima T, Okita K, Takada K. (1999). J Virol 73: 1286-1292.
15. Sall A, Caserta S, Jolicoeur P, Franqueville L, de Turenne-Tessier M, Ooka T. (2004). Oncogene 23: 4938-4944.
16. Sarkar S, Pollack BP, Lin KT, Kotenko SV, Cook JR, Lewis A et al. (2001). J Biol Chem 276: 49034-49042.
17. Schaaf CP, Benzing J, Schmitt T, Erz DH, Tewes M, Bartram CR et al. (2005). FASEB J 19: 267-269.
18. Schilling B, De-Medina T, Syken J, Vidai M, Munger K. (1998). Virology 247: 74-85.
19. Seto E, Yang L, Middeldorp J, Sheen TS, Chen JY, Fukayama M et al. (2005). J Med Virol 76: 82-88.
20. Sheng W, Decaussin G, Ligout A, Takada K, Ooka T. (2003). J Virol 77: 3859-3865.
21. Sheng W, Decaussin G, Sumner S, Ooka T. (2001). Oncogene 20: 1176-1185.
22. Strockbine LD, Cohen JI, Farrah T, Lyman SD, Wagener F, DuBose RF et al. (1998). J Virol 72: 4015-4021.
23. Syken J, De-Medina T, Munger K. (1999). Proc Natl Acad Sci USA 96: 8499-9504.
24. Wang CC, Ng CP, Lu L, Atlashkin V, Zhang W, Seet LF et al. (2004). Dev Cell 7: 359-371.
25. Wei MX, de Turenne-Tessier M, Decaussin G, Benet G, Ooka T. (1997). Oncogene 14: 3073-3081.
26. Wei MX, Moulin JC, Decaussin G, Berger F, Ooka T. (1994). Cancer Res 54: 1843-1848.
27. Wei MX, Ooka T. (1989). EMBO J 8: 2897-2903.
28. Zhang CX, Decaussin G, Daillie J, Ooka T. (1988). J Virol 62: 1862-1869.